PR Newswire

Sleep Apnea Devices Market Size & Share to Surpass USD 20 Billion by 2035 | Roots Analysis

The global sleep apnea devices market is growing rapidly; it is estimated to be worth USD 13.5 billion in 2023 and is anticipated to reach over USD 20 billion by 2035. It is expected to grow at a ...

Sleep Apnea Diagnostic Systems Market Report 2025: Key Segments, Share, Regulatory, Reimbursement, Installed Base and Forecasts 2015-2036

Key market opportunities for Sleep Apnea Diagnostic Systems include expanding in emerging markets, leveraging global insights to inform regional strategies, and enhancing competitive positioning ...
KTLA

Sleep Apnea Devices Market to Surpass Valuation of USD 19.65 Billion by 2031 | SkyQuest Technology

The Global Sleep Apnea Devices Market is set to soar from USD 5.4 billion in 2023 to USD 19.65 billion by 2031, with a strong CAGR of 7.32%! WESTFORD, MA, UNITED ...
PR Newswire

Sleep Apnea Devices Market worth $9.3 billion by 2029 driven by Rising Technological Advancements | MarketsandMarkets™

ResMed (US) led the sleep apnea devices market in 2023, renowned for its innovative and advanced therapeutic and diagnostic devices. The company's focus on healthcare technology expertise enables it ...
MobiHealthNews

Snoozeal reveals work on snoring and sleep apnea device, smartphone app

While tens of millions of people live with snoring or obstructive sleep apnea, the most commonly prescribed treatment – a CPAP mask – has historically low adherence rates. So London-based Snoozeal has ...
MarketWatch

Sleep Apnea Market to Accelerate Substantially at a CAGR of 20% During the Study Period (2020-2034) | DelveInsight

LAS VEGAS, July 2, 2025 /PRNewswire/ -- DelveInsight's Sleep Apnea Market Insights report includes a comprehensive understanding of current treatment practices, sleep apnea emerging drugs, market ...
vator

VP of Withings Health Solutions talks newly FDA approved Sleep RX device

Roughly 30 million adults in the U.S. have Obstructive Sleep Apnea (OSA), with millions of patients going undiagnosed, which can increase the risk of a number of diseases, including diabetes mellitus, ...
Hosted on MSN

ResMed's SWOT analysis: sleep tech giant faces GLP-1 drug challenge

ResMed Inc . (NYSE:RMD; ASX:RMD), a leading player in the sleep and respiratory care market, has demonstrated strong operational performance in recent quarters. However, the company faces potential ...
Nasdaq

ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy ...

SAN DIEGO, Feb. 12, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) launched today its AirCurve 11 series devices, the company’s newest bilevel devices that use two levels of support, ...
Nasdaq

LivaNova's OSPREY Sleep Apnea Trail on aura6000 Meets Primary Endpoint

LivaNova’s LIVN OSPREY trial, evaluating the aura6000 nerve stimulation system for obstructive sleep apnea (OSA), has delivered promising results. By meeting primary safety and efficacy endpoints, the ...
Hosted on MSN

We Tested Sleep Trackers and These Are the Only Ones Worth Your Money

There’s so much advice out there about how to fall asleep, how to stay asleep, how many hours of sleep you need, what to eat before bed for better sleep—you could spend months, if not years, trying ...